EGFR and non-small cell lung carcinoma: Zou et al demonstrated that some Ktrans and Kep features were reliable in evaluating the epidermal growth factor receptor (EGFR) gene mutation status and the expression of vascular endothelial growth factor (VEGF) and EGFR proteins in NSCLC [28].